Insights

Expanding Global Presence SOMAÍ's rapid international growth through acquisitions and partnerships across Europe and beyond indicates a strong demand for its cannabis-based therapeutics, presenting opportunities for businesses interested in distributing or collaborating within the expanding global medical cannabis market.

Innovative Product Pipeline With a robust pipeline of cannabis-derived therapeutics and recent EU-GMP full-spectrum extract launches, SOMAÍ demonstrates ongoing innovation that can open doors to healthcare providers, pharmacies, and clinics seeking high-quality, pharmaceutical-grade cannabis solutions.

Strategic Partnerships Recent collaborations with companies like Sherbinskis, Releaf Dispensary, and Canymed position SOMAÍ as a key partner for distribution, offering opportunities to leverage its expansive network for product placement and co-marketing in multiple European markets.

Vertical Integration Advantage Having fully integrated manufacturing and cultivation facilities in Lisbon allows SOMAÍ to assure product quality and consistency, making it an ideal partner for premium cannabis products targeting medical markets eager for reliable, pharmaceutical-grade therapeutics.

Financial Stability and Funding Backed by $10 million in funding and strategic acquisitions, SOMAÍ is well-positioned for further growth and market penetration, presenting sales prospects with a stable and expanding company eager to establish new distribution channels and product collaborations.

SOMAÍ Tech Stack

SOMAÍ uses 8 technology products and services including Adobe Illustrator, Microsoft Excel, Sage, and more. Explore SOMAÍ's tech stack below.

Adobe Illustrator

Cad & Graphics

Microsoft Excel

Editors

Sage

Enterprise Resource Planning

Asana

Issue Trackers

Microsoft Word

Office Suites

Microsoft Office

Office Suites

Extendify

Web Platform Extensions

Nginx

Web Servers

SOMAÍ Email Formats	Example	Percentage
FL@somaipharma.eu	JD@somaipharma.eu	92%
LF@somaipharma.eu	DJ@somaipharma.eu	5%
First.Last@somaipharma.eu	John.Doe@somaipharma.eu	3%

SOMAÍ Email Formats

Example

Percentage

FL@somaipharma.eu

JD@somaipharma.eu

92%

LF@somaipharma.eu

DJ@somaipharma.eu

First.Last@somaipharma.eu

John.Doe@somaipharma.eu

Frequently Asked Questions

Where is SOMAÍ's headquarters located?

SOMAÍ's main headquarters is located at Lisbon Portugal. The company has employees across 5 continents, including EuropeOceaniaAsia.

What is SOMAÍ's official website and social media links?

SOMAÍ's official website is somaipharma.eu and has social profiles on LinkedIn Crunchbase.

What is SOMAÍ's NAICS code?

SOMAÍ's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does SOMAÍ have currently?

As of June 2026, SOMAÍ has approximately 66 employees across 5 continents, including EuropeOceaniaAsia. Key team members include Co-Founder Somai Pharmaceuticals: G. B.Interim Ceo: M. S.Quality Control Director: J. C.. Explore SOMAÍ's employee directory with LeadIQ.

What industry does SOMAÍ belong to?

SOMAÍ operates in the Pharmaceutical Manufacturing industry.

What technology does SOMAÍ use?

SOMAÍ's tech stack includes Adobe IllustratorMicrosoft ExcelSageAsanaMicrosoft WordMicrosoft OfficeExtendifyNginx.

What is SOMAÍ's email format?

SOMAÍ's email format typically follows the pattern of FL@somaipharma.eu. Find more SOMAÍ email formats with LeadIQ.

How much funding has SOMAÍ raised to date?

As of June 2026, SOMAÍ has raised $10M in funding. The last funding round occurred on Jul 15, 2024 for $10M.

When was SOMAÍ founded?

SOMAÍ was founded in 2019.

SOMAÍ

Q: What is SOMAÍ's official website and social media links?

SOMAÍ's official website is somaipharma.eu. SOMAÍ has social profiles on LinkedIn.

Q: How many employees does SOMAÍ have currently?

SOMAÍ has approximately 66 employees.

Q: What technology does SOMAÍ use?

SOMAÍ's tech stack includes Akamai Bot Manager, HTML, Microsoft Project, Microsoft Word, FlippingBook.

Q: What is SOMAÍ's NAICS code?

SOMAÍ's NAICS code is 3254 (Pharmaceutical and Medicine Manufacturing).

Pharmaceutical ManufacturingLisbon, Portugal51-200 Employees

SOMAÍ is a leading EU-GMP European vertically integrated Multi-Country Operator (MCO) company with a global footprint of distribution for the largest and most advanced EU GMP-certified cannabinoid-containing pharmaceutical extract portfolio.

At SOMAÍ, we are building a leading global brand with the most robust pipeline of innovative cannabis-based therapeutics. We envision a world where people live a healthy lifestyle empowered by natural cannabis medicine.

SOMAÍ owns a state-of-the-art manufacturing facility and indoor cultivation in Lisbon, Portugal, and has global sales teams in the largest medical cannabis markets. We are continuing to make acquisitions and global brand partnerships that make us one of a few and the first European-based vertically integrated companies in the EU able to cater to the diverse needs of fast-growing global cannabis markets.

Insights

Similar companies to SOMAÍ

Roche

Bristol Myers Squibb

Sanofi

Johnson & Johnson

Pfizer

AstraZeneca

AbbVie

Novartis

Bayer

Amgen

SOMAÍ Tech Stack

Media & News

SOMAÍ Pharmaceuticals Inc. partners with Sherbinskis.

SOMAÍ Pharmaceuticals Inc. launches EU-GMP full-spectrum Essentials line extracts.

SOMAÍ Pharmaceuticals Inc. partnered with Releaf Dispensary Limited on Oct 9th '24.

SOMAÍ Pharmaceuticals Inc. hires Tom Flow.

SOMAÍ Pharmaceuticals Inc. acquires RPK Biopharma for $2M.

Akanda Corp. sells assets to SOMAÍ Pharmaceuticals Inc. in the amount of $2M.

SOMAÍ Pharmaceuticals Inc. partners with Canymed GmbH.

SOMAÍ's Email Address Formats